Hypoxia-induced and stress-specific changes in chromatin structure and function

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 618, Issue 1-2, 2007, Pages 149-162

  Johnson, Amber Buescher ^a   Barton, Michelle Craig ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Cellular stress; Chromatin structure; Hypoxia; Oxidative stress

Indexed keywords

HISTONE DEACETYLASE;

ACETYLATION; ARTICLE; CELL FUNCTION; CELL STRESS; CHROMATIN STRUCTURE; DEACETYLATION; DNA DAMAGE; GENE CONTROL; GENE EXPRESSION; HUMAN; HYPOXIA; PRIORITY JOURNAL; PROTEIN METHYLATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; TUMOR;

ANIMALS; ANOXIA; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA DAMAGE; GENE EXPRESSION REGULATION; HEAT-SHOCK RESPONSE; HISTONE ACETYLTRANSFERASES; HISTONES; HUMANS; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN BINDING; TRANSCRIPTION, GENETIC;

EID: 34147161066     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2006.10.007     Document Type: Article

References (122)

1. Luger K., Mader A.W., Richmond R.K., Sargent D.F., and Richmond T.J. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389 (1997) 251-260
2. Kornberg R.D., and Lorch Y. Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell 98 (1999) 285-294
3. Narlikar G.J., Fan H.Y., and Kingston R.E. Cooperation between complexes that regulate chromatin structure and transcription. Cell 108 (2002) 475-487
4. Bode A.M., and Dong Z. Inducible covalent posttranslational modification of histone H3. Sci. STKE 2005 (2005) re4
5. Imhof A. Histone modifications: an assembly line for active chromatin?. Curr. Biol. 13 (2003) R22-R24
6. Jenuwein T., and Allis C.D. Translating the histone code. Science 293 (2001) 1074-1080
7. Lusser A. Acetylated, methylated, remodeled: chromatin states for gene regulation. Curr. Opin. Plant Biol. 5 (2002) 437-443
8. Kim M.Y., Zhang T., and Kraus W.L. Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD+ into a nuclear signal. Genes Dev. 19 (2005) 1951-1967
9. Vidanes G.M., Bonilla C.Y., and Toczyski D.P. Complicated tails: histone modifications and the DNA damage response. Cell 121 (2005) 973-976
10. Moggs J.G., and Orphanides G. The role of chromatin in molecular mechanisms of toxicity. Toxicol. Sci. 80 (2004) 218-224
11. van Attikum H., and Gasser S.M. The histone code at DNA breaks: a guide to repair?. Nat. Rev. Mol. Cell Biol. 6 (2005) 757-765
12. Hockel M., and Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J. Natl. Cancer Inst. 93 (2001) 266-276
13. Vaupel P., and Harrison L. Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. Oncologist 9 Suppl. 5 (2004) 4-9
14. Vaupel P., and Mayer A. Hypoxia and anemia: effects on tumor biology and treatment resistance. Transfus. Clin. Biol. 12 (2005) 5-10
15. Brahimi-Horn C., Berra E., and Pouyssegur J. Hypoxia: the tumor's gateway to progression along the angiogenic pathway. Trends Cell Biol. 11 (2001) S32-S36
16. Vaupel P., Thews O., and Hoeckel M. Treatment resistance of solid tumors: role of hypoxia and anemia. Med. Oncol. 18 (2001) 243-259
17. Lee J.W., Bae S.H., Jeong J.W., Kim S.H., and Kim K.W. Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp. Mol. Med. 36 (2004) 1-12
18. Harris A.L. Hypoxia-a key regulatory factor in tumour growth. Nat. Rev. Cancer 2 (2002) 38-47
19. 2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell Dev. Biol. 15 (1999) 551-578
20. Semenza G.L. HIF-1 and human disease: one highly involved factor. Genes Dev. 14 (2000) 1983-1991
21. Maxwell P.H., Pugh C.W., and Ratcliffe P.J. Activation of the HIF pathway in cancer. Curr. Opin. Genet. Dev. 11 (2001) 293-299
22. Semenza G.L. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol. Med. 7 (2001) 345-350
23. Guillemin K., and Krasnow M.A. The hypoxic response: huffing and HIFing. Cell 89 (1997) 9-12
24. Jeong J.W., Bae M.K., Ahn M.Y., Kim S.H., Sohn T.K., Bae M.H., Yoo M.A., Song E.J., Lee K.J., and Kim K.W. Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation. Cell 111 (2002) 709-720
25. Lando D., Peet D.J., Whelan D.A., Gorman J.J., and Whitelaw M.L. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295 (2002) 858-861
26. Hewitson K.S., McNeill L.A., Riordan M.V., Tian Y.M., Bullock A.N., Welford R.W., Elkins J.M., Oldham N.J., Bhattacharya S., Gleadle J.M., Ratcliffe P.J., Pugh C.W., and Schofield C.J. Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J. Biol. Chem. 277 (2002) 26351-26355
27. Bardos J.I., and Ashcroft M. Negative and positive regulation of HIF-1: a complex network. Biochim. Biophys. Acta 1755 (2005) 107-120
28. Mazure N.M., Brahimi-Horn M.C., Berta M.A., Benizri E., Bilton R.L., Dayan F., Ginouves A., Berra E., and Pouyssegur J. HIF-1: master and commander of the hypoxic world. A pharmacological approach to its regulation by siRNAs. Biochem. Pharmacol. 68 (2004) 971-980
29. Hirota K., and Semenza G.L. Regulation of hypoxia-inducible factor 1 by prolyl and asparaginyl hydroxylases. Biochem. Biophys. Res. Commun. 338 (2005) 610-616
30. Eberharter A., and Becker P.B. Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics. EMBO Rep. 3 (2002) 224-229
31. Carrero P., Okamoto K., Coumailleau P., O'Brien S., Tanaka H., and Poellinger L. Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha. Mol. Cell Biol. 20 (2000) 402-415
32. Kallio P.J., Okamoto K., O'Brien S., Carrero P., Makino Y., Tanaka H., and Poellinger L. Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha. Embo J. 17 (1998) 6573-6586
33. Kalkhoven E. CBP and p300: HATs for different occasions. Biochem. Pharmacol. 68 (2004) 1145-1155
34. Kasper L.H., Boussouar F., Boyd K., Xu W., Biesen M., Rehg J., Baudino T.A., Cleveland J.L., and Brindle P.K. Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive gene expression. Embo J. 24 (2005) 3846-3858
35. Arany Z., Huang L.E., Eckner R., Bhattacharya S., Jiang C., Goldberg M.A., Bunn H.F., and Livingston D.M. An essential role for p300/CBP in the cellular response to hypoxia. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 12969-12973
36. Ebert B.L., and Bunn H.F. Regulation of transcription by hypoxia requires a multiprotein complex that includes hypoxia-inducible factor 1, an adjacent transcription factor, and p300/CREB binding protein. Mol. Cell Biol. 18 (1998) 4089-4096
37. Kung A.L., Wang S., Klco J.M., Kaelin W.G., and Livingston D.M. Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat. Med. 6 (2000) 1335-1340
38. Ruas J.L., Poellinger L., and Pereira T. Role of CBP in regulating HIF-1-mediated activation of transcription. J. Cell Sci. 118 (2005) 301-311
39. Ruas J.L., Poellinger L., and Pereira T. Functional analysis of hypoxia-inducible factor-1 alpha-mediated transactivation. Identification of amino acid residues critical for transcriptional activation and/or interaction with CREB-binding protein. J. Biol. Chem. 277 (2002) 38723-38730
40. Jung J.E., Lee H.G., Cho I.H., Chung D.H., Yoon S.H., Yang Y.M., Lee J.W., Choi S., Park J.W., Ye S.K., and Chung M.H. STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells. FASEB J. 19 (2005) 1296-1298
41. Sang N., Stiehl D.P., Bohensky J., Leshchinsky I., Srinivas V., and Caro J. MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300. J. Biol. Chem. 278 (2003) 14013-14019
42. Gu J., Milligan J., and Huang L.E. Molecular mechanism of hypoxia-inducible factor 1alpha-p300 interaction. A leucine-rich interface regulated by a single cysteine. J. Biol. Chem. 276 (2001) 3550-3554
43. Yasinska I.M., and Sumbayev V.V. S-Nitrosation of Cys-800 of HIF-1alpha protein activates its interaction with p300 and stimulates its transcriptional activity. FEBS Lett. 549 (2003) 105-109
44. Schmid T., Zhou J., Kohl R., and Brune B. p300 relieves p53-evoked transcriptional repression of hypoxia-inducible factor-1 (HIF-1). Biochem. J. 380 (2004) 289-295
45. Freedman S.J., Sun Z.Y., Poy F., Kung A.L., Livingston D.M., Wagner G., and Eck M.J. Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 5367-5372
46. Bhattacharya S., Michels C.L., Leung M.K., Arany Z.P., Kung A.L., and Livingston D.M. Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. Genes Dev. 13 (1999) 64-75
47. Fox S.B., Braganca J., Turley H., Campo L., Han C., Gatter K.C., Bhattacharya S., and Harris A.L. CITED4 inhibits hypoxia-activated transcription in cancer cells, and its cytoplasmic location in breast cancer is associated with elevated expression of tumor cell hypoxia-inducible factor 1alpha. Cancer Res. 64 (2004) 6075-6081
48. Freedman S.J., Sun Z.Y., Kung A.L., France D.S., Wagner G., and Eck M.J. Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2. Nat. Struct. Biol. 10 (2003) 504-512
49. Yin Z., Haynie J., Yang X., Han B., Kiatchoosakun S., Restivo J., Yuan S., Prabhakar N.R., Herrup K., Conlon R.A., Hoit B.D., Watanabe M., and Yang Y.C. The essential role of Cited2, a negative regulator for HIF-1alpha, in heart development and neurulation. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 10488-10493
50. Mahon P.C., Hirota K., and Semenza G.L. FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 15 (2001) 2675-2686
51. Lando D., Peet D.J., Gorman J.J., Whelan D.A., Whitelaw M.L., and Bruick R.K. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 16 (2002) 1466-1471
52. Dann C.E., 3rd R.K., Bruick J., and Deisenhofer. Structure of factor-inhibiting hypoxia-inducible factor 1: an asparaginyl hydroxylase involved in the hypoxic response pathway. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 15351-15356
53. Ozer A., Wu L.C., and Bruick R.K. The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF). Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 7481-7486
54. Koukourakis M.I., Giatromanolaki A., Sivridis E., Gatter K.C., and Harris A.L. Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma. Neoplasia 7 (2005) 1-6
55. Costa M., Davidson T.L., Chen H., Ke Q., Zhang P., Yan Y., Huang C., and Kluz T. Nickel carcinogenesis: epigenetics and hypoxia signaling. Mutat. Res. 592 (2005) 79-88
56. McKinsey T.A., Kuwahara K., Bezprozvannaya S., and Olson E.N. Class II histone deacetylases confer signal responsiveness to the ankyrin-repeat proteins ANKRA2 and RFXANK. Mol. Biol. Cell 17 (2006) 438-447
57. Khochbin S., Verdel A., Lemercier C., and Seigneurin-Berny D. Functional significance of histone deacetylase diversity. Curr. Opin. Genet. Dev. 11 (2001) 162-166
58. Gregoretti I.V., Lee Y.M., and Goodson H.V. Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. J. Mol. Biol. 338 (2004) 17-31
59. Gao L., Cueto M.A., Asselbergs F., and Atadja P. Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family. J. Biol. Chem. 277 (2002) 25748-25755
60. Islam K.N., and Mendelson C.R. Permissive effects of oxygen on cyclic AMP and interleukin-1 stimulation of surfactant protein A gene expression are mediated by epigenetic mechanisms. Mol. Cell Biol. 26 (2006) 2901-2912
61. Hoffman W.H., Biade S., Zilfou J.T., Chen J., and Murphy M. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J. Biol. Chem. 277 (2002) 3247-3257
62. Murai M., Toyota M., Satoh A., Suzuki H., Akino K., Mita H., Sasaki Y., Ishida T., Shen L., Garcia-Manero G., Issa J.P., Hinoda Y., Tokino T., and Imai K. Aberrant DNA methylation associated with silencing BNIP3 gene expression in haematopoietic tumours. Br. J. Cancer. 92 (2005) 1165-1172
63. Mihaylova V.T., Bindra R.S., Yuan J., Campisi D., Narayanan L., Jensen R., Giordano F., Johnson R.S., Rockwell S., and Glazer P.M. Decreased expression of the DNA mismatch repair gene Mlh1 under hypoxic stress in mammalian cells. Mol. Cell Biol. 23 (2003) 3265-3273
64. Alland L., Muhle R., Hou Jr. H., Potes J., Chin L., Schreiber-Agus N., and DePinho R.A. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387 (1997) 49-55
65. Hassig C.A., Fleischer T.C., Billin A.N., Schreiber S.L., and Ayer D.E. Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89 (1997) 341-347
66. Laherty C.D., Yang W.M., Sun J.M., Davie J.R., Seto E., and Eisenman R.N. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 89 (1997) 349-356
67. Krieg A.J., Hammond E.M., and Giaccia A.J. Functional analysis of p53 binding under differential stresses. Mol. Cell Biol. 26 (2006) 7030-7045
68. Williams R.J., and Trichostatin A. An inhibitor of histone deacetylase, inhibits hypoxia-induced angiogenesis. Expert Opin. Investig. Drugs 10 (2001) 1571-1573
69. Kwon H.J., Kim M.S., Kim M.J., Nakajima H., and Kim K.W. Histone deacetylase inhibitor FK228 inhibits tumor angiogenesis. Int. J. Cancer 97 (2002) 290-296
70. Lin H.Y., Chen C.S., Lin S.P., Weng J.R., and Chen C.S. Targeting histone deacetylase in cancer therapy. Med. Res. Rev. 26 (2006) 397-413
71. Kim M.S., Kwon H.J., Lee Y.M., Baek J.H., Jang J.E., Lee S.W., Moon E.J., Kim H.S., Lee S.K., Chung H.Y., Kim C.W., and Kim K.W. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat. Med. 7 (2001) 437-443
72. Qian D.Z., Wang X., Kachhap S.K., Kato Y., Wei Y., Zhang L., Atadja P., and Pili R. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584. Cancer Res. 64 (2004) 6626-6634
73. Kong X., Lin Z., Liang D., Fath D., Sang N., and Caro J. Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha. Mol. Cell Biol. 26 (2006) 2019-2028
74. Fath D.M., Kong X., Liang D., Lin Z., Chou A., Jiang Y., Fang J., Caro J., and Sang N. Histone deacetylase inhibitors repress the transactivation potential of hypoxia inducible factors independently of direct acetylation of HIF-alpha. J. Biol. Chem. (2006)
75. Waypa G.B., and Schumacker P.T. O(2) sensing in hypoxic pulmonary vasoconstriction: the mitochondrial door re-opens. Respir. Physiol. Neurobiol. 132 (2002) 81-91
76. Waypa G.B., and Schumacker P.T. Hypoxic pulmonary vasoconstriction: redox events in oxygen sensing. J. Appl. Physiol. 98 (2005) 404-414
77. Rahman I., Marwick J., and Kirkham P. Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression. Biochem. Pharmacol. 68 (2004) 1255-1267
78. Adcock I.M., Cosio B., Tsaprouni L., Barnes P.J., and Ito K. Redox regulation of histone deacetylases and glucocorticoid-mediated inhibition of the inflammatory response. Antioxid. Redox Signal 7 (2005) 144-152
79. Baumeister P., Luo S., Skarnes W.C., Sui G., Seto E., Shi Y., and Lee A.S. Endoplasmic reticulum stress induction of the Grp78/BiP promoter: activating mechanisms mediated by YY1 and its interactive chromatin modifiers. Mol. Cell Biol. 25 (2005) 4529-4540
80. Liu L., Cash T.P., Jones R.G., Keith B., Thompson C.B., and Simon M.C. Hypoxia-induced energy stress regulates mRNA translation and cell growth. Mol. Cell 21 (2006) 521-531
81. Clayton A.L., and Mahadevan L.C. MAP kinase-mediated phosphoacetylation of histone H3 and inducible gene regulation. FEBS Lett. 546 (2003) 51-58
82. Dunn K.L., Espino P.S., Drobic B., He S., and Davie J.R. The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling. Biochem. Cell Biol. 83 (2005) 1-14
83. Barratt M.J., Hazzalin C.A., Cano E., and Mahadevan L.C. Mitogen-stimulated phosphorylation of histone H3 is targeted to a small hyperacetylation-sensitive fraction. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 4781-4785
84. Clayton A.L., Rose S., Barratt M.J., and Mahadevan L.C. Phosphoacetylation of histone H3 on c-fos- and c-jun-associated nucleosomes upon gene activation. Embo J. 19 (2000) 3714-3726
85. Feng J.L., and Villeponteau B. Serum stimulation of the c-fos enhancer induces reversible changes in c-fos chromatin structure. Mol. Cell Biol. 10 (1990) 1126-1133
86. Feng J., and Villeponteau B. High-resolution analysis of c-fos chromatin accessibility using a novel DNase I-PCR assay. Biochim. Biophys. Acta 1130 (1992) 253-258
87. Martin C., and Zhang Y. The diverse functions of histone lysine methylation. Nat. Rev. Mol. Cell Biol. 6 (2005) 838-849
88. Sims R.J., 3rd K., Nishioka D., and Reinberg. Histone lysine methylation: a signature for chromatin function. Trends Genet. 19 (2003) 629-639
89. Zhang Y., and Reinberg D. Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev. 15 (2001) 2343-2360
90. Miao F., Li S., Chavez V., Lanting L., and Natarajan R. CARM1 enhances NF-{kappa}B mediated gene transcription through methylation of histone H3 at arginine 17. Mol. Endocrinol. 20 (2006) 1562-1573
91. Huang S., Litt M., and Felsenfeld G. Methylation of histone H4 by arginine methyltransferase PRMT1 is essential in vivo for many subsequent histone modifications. Genes Dev. 19 (2005) 1885-1893
92. Wang H., Huang Z.Q., Xia L., Feng Q., Erdjument-Bromage H., Strahl B.D., Briggs S.D., Allis C.D., Wong J., Tempst P., and Zhang Y. Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science 293 (2001) 853-857
93. Wang F., Zhang R., Beischlag T.V., Muchardt C., Yaniv M., and Hankinson O. Roles of Brahma and Brahma/SWI2-related gene 1 in hypoxic induction of the erythropoietin gene. J. Biol. Chem. 279 (2004) 46733-46741
94. Kadam S., McAlpine G.S., Phelan M.L., Kingston R.E., Jones K.A., and Emerson B.M. Functional selectivity of recombinant mammalian SWI/SNF subunits. Genes Dev. 14 (2000) 2441-2451
95. Kadam S., and Emerson B.M. Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes. Mol. Cell 11 (2003) 377-389
96. Damelin M., Simon I., Moy T.I., Wilson B., Komili S., Tempst P., Roth F.P., Young R.A., Cairns B.R., and Silver P.A. The genome-wide localization of Rsc9, a component of the RSC chromatin-remodeling complex, changes in response to stress. Mol. Cell 9 (2002) 563-573
97. Sullivan E.K., Weirich C.S., Guyon J.R., Sif S., and Kingston R.E. Transcriptional activation domains of human heat shock factor 1 recruit human SWI/SNF. Mol. Cell Biol. 21 (2001) 5826-5837
98. Hassa P.O., and Hottiger M.O. An epigenetic code for DNA damage repair pathways?. Biochem. Cell Biol. 83 (2005) 270-285
99. Koumenis C., Alarcon R., Hammond E., Sutphin P., Hoffman W., Murphy M., Derr J., Taya Y., Lowe S.W., Kastan M., and Giaccia A. Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Mol. Cell Biol. 21 (2001) 1297-1310
100. Hammond E.M., Dorie M.J., and Giaccia A.J. ATR/ATM targets are phosphorylated by ATR in response to hypoxia and ATM in response to reoxygenation. J. Biol. Chem. 278 (2003) 12207-12213
101. Greijer A.E., and van der Wall E. The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J. Clin. Pathol. 57 (2004) 1009-1014
102. McClintock D.S., Santore M.T., Lee V.Y., Brunelle J., Budinger G.R., Zong W.X., Thompson C.B., Hay N., and Chandel N.S. Bcl-2 family members and functional electron transport chain regulate oxygen deprivation-induced cell death. Mol. Cell Biol. 22 (2002) 94-104
103. Graeber T.G., Osmanian C., Jacks T., Housman D.E., Koch C.J., Lowe S.W., and Giaccia A.J. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379 (1996) 88-91
104. Kim J.Y., Ahn H.J., Ryu J.H., Suk K., and Park J.H. BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1alpha. J. Exp. Med. 199 (2004) 113-124
105. Papandreou I., Krishna C., Kaper F., Cai D., Giaccia A.J., and Denko N.C. Anoxia is necessary for tumor cell toxicity caused by a low-oxygen environment. Cancer Res. 65 (2005) 3171-3178
106. Risuleo G., Cristofanilli M., and Scarsella G. Acute ischemia/hypoxia in rat hippocampal neurons activates nuclear ubiquitin and alters both chromatin and DNA. Mol. Cell Biochem. 250 (2003) 73-80
107. Rogakou E.P., Nieves-Neira W., Boon C., Pommier Y., and Bonner W.M. Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139. J. Biol. Chem. 275 (2000) 9390-9395
108. Cheung W.L., Ajiro K., Samejima K., Kloc M., Cheung P., Mizzen C.A., Beeser A., Etkin L.D., Chernoff J., Earnshaw W.C., and Allis C.D. Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. Cell 113 (2003) 507-517
109. Hendzel M.J., Nishioka W.K., Raymond Y., Allis C.D., Bazett-Jones D.P., and Th'ng J.P. Chromatin condensation is not associated with apoptosis. J. Biol. Chem. 273 (1998) 24470-24478
110. Lee E., Nakatsuma A., Hiraoka R., Ishikawa E., Enomoto R., and Yamauchi A. Involvement of histone phosphorylation in thymocyte apoptosis by protein phosphatase inhibitors. IUBMB Life 48 (1999) 79-83
111. Waring P., Khan T., and Sjaarda A. Apoptosis induced by gliotoxin is preceded by phosphorylation of histone H3 and enhanced sensitivity of chromatin to nuclease digestion. J. Biol. Chem. 272 (1997) 17929-17936
112. Kratzmeier M., Albig W., Hanecke K., and Doenecke D. Rapid dephosphorylation of H1 histones after apoptosis induction. J. Biol. Chem. 275 (2000) 30478-30486
113. Boix-Chornet M., Fraga M.F., Villar-Garea A., Caballero R., Espada J., Nunez A., Casado J., Largo C., Casal J.I., Cigudosa J.C., Franco L., Esteller M., and Ballestar E. Release of hypoacetylated and tri-methylated histone H4 is an epigenetic marker of early apoptosis. J. Biol. Chem. 281 (2006) 13540-13547
114. Gardner L.B., Li Q., Park M.S., Flanagan W.M., Semenza G.L., and Dang C.V. Hypoxia inhibits G1/S transition through regulation of p27 expression. J. Biol. Chem. 276 (2001) 7919-7926
115. Green S.L., Freiberg R.A., and Giaccia A.J. p21(Cip1) and p27(Kip1) regulate cell cycle reentry after hypoxic stress but are not necessary for hypoxia-induced arrest. Mol. Cell Biol. 21 (2001) 1196-1206
116. Graeber T.G., Peterson J.F., Tsai M., Monica K., Fornace Jr. A.J., and Giaccia A.J. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell Biol. 14 (1994) 6264-6277
117. Hajeri V.A., Trejo J., and Padilla P.A. Characterization of sub-nuclear changes in Caenorhabditis elegans embryos exposed to brief, intermediate and long-term anoxia to analyze anoxia-induced cell cycle arrest. BMC Cell Biol. 6 (2005) 47
118. Pusarla R.H., and Bhargava P. Histones in functional diversification. Core histone variants. FEBS J. 272 (2005) 5149-5168
119. Kasprzak K.S. Oxidative DNA and protein damage in metal-induced toxicity and carcinogenesis. Free Radic. Biol. Med. 32 (2002) 958-967
120. Konat G.W. Higher order chromatin degradation: implications for neurodegeneration. Neurochem. Res. 27 (2002) 1447-1451
121. Tulin A., and Spradling A. Chromatin loosening by poly(ADP)-ribose polymerase (PARP) at Drosophila puff loci. Science 299 (2003) 560-562
122. Hirota K., Hasemi T., Yamada T., Mizuno K.I., Hoffman C.S., Shibata T., and Ohta K. Fission yeast global repressors regulate the specificity of chromatin alteration in response to distinct environmental stresses. Nucl. Acids Res. 32 (2004) 855-862